EMERYVILLE, Calif., Dec. 11, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it received ISO (International Organization for Standardization) 13485 certification from the notified body DEKRA, for its quality management system. This is an important milestone supporting the manufacturing and commercialization of NovaBay's NeutroPhase® skin and wound cleanser.
Help employers find you! Check out all the jobs and post your resume.
